
Results
5
Companies which are potentially undervalued and in an acceptable financial position.
5 companies
Merck KGaA
Market Cap: €45.2b
Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MRK
€102.70
7D
-5.1%
1Y
-21.2%
SCHOTT Pharma KGaA
Market Cap: €2.0b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€13.06
7D
-3.1%
1Y
-44.7%
Bayer
Market Cap: €37.7b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€38.47
7D
-4.1%
1Y
71.6%
Evotec
Market Cap: €762.0m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€4.15
7D
-2.7%
1Y
-37.5%
Formycon
Market Cap: €301.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€17.28
7D
-10.6%
1Y
-35.8%